IDEXX Laboratories (MEX:IDXX) 3-Year Share Buyback Ratio : 1.20% (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is IDEXX Laboratories 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. IDEXX Laboratories's current 3-Year Share Buyback Ratio was 1.20%.

The historical rank and industry rank for IDEXX Laboratories's 3-Year Share Buyback Ratio or its related term are showing as below:

MEX:IDXX' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -21.4 Med: 1.9 Max: 6.2
Current: 1.2

During the past 13 years, IDEXX Laboratories's highest 3-Year Share Buyback Ratio was 6.20%. The lowest was -21.40%. And the median was 1.90%.

MEX:IDXX's 3-Year Share Buyback Ratio is ranked better than
93.22% of 177 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.6 vs MEX:IDXX: 1.20

Competitive Comparison of IDEXX Laboratories's 3-Year Share Buyback Ratio

For the Diagnostics & Research subindustry, IDEXX Laboratories's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDEXX Laboratories's 3-Year Share Buyback Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

IDEXX Laboratories 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

IDEXX Laboratories (MEX:IDXX) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

IDEXX Laboratories 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEXX Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (MEX:IDXX) » Definitions » 3-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

IDXX:USA 0J8P:UK IX1:Germany IX1:Germany I1DX34:Brazil

Address

One IDEXX Drive, Westbrook, ME, USA, 04092

Website

https://www.idexx.com

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.